A phase Ib/II study of niraparib combination therapies for the treatment of metastatic castration-resistant prostate cancer (NCT03431350). Meeting Abstract

cited authors

  • Subudhi, Sumit Kumar; Aparicio, Ana; Zurita, Amado J.; Doger, Bernard; Kelly, William Kevin; Peer, Avivit; Rathkopf, Dana E.; Karsh, Lawrence Ivan; Tryon, Jeffrey J.; Kothari, Nishi; Zhao, Xin; Zhu, Eugene; Ricci, Deborah S.; Namphuong Tran; De Bono, Johann S.

Publication Date

  • May 20, 2019

webpage

published in

category

volume

  • 37

issue

  • 15